PMI

PMI GROUP INC (THE)

PMI

Overview Fund Activity

Delisted

PMI was delisted on the 28th of October, 2011.

Back to rankings

Financials Property & Casualty Insurance

Financial journalist opinion

Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering

TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at $4.00 per share (the “Offering”). The Company has granted the underwriters an option, within 30 days from the closing date of the Offering, to purchase up to an additional 637,500 shares of Common Stock the public offering price, less underwriting discounts, to cover over-allotment, if any. The gross proceeds from the offering were $17 million, before deducting underwriting discounts and estimated offering expenses. The shares began trading on the NYSE American, LLC (“NYSE American”) under the ticker symbol “PMI” on August 29, 2025.

Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering

U.S. IPO Weekly Recap: Quiet Week As IPO Market Gears Up For A Busy Fall

Four small issuers and two SPACs priced offerings in the past week, and a few names joined the pipeline. The largest deals of the week came from the pair of blank check IPOs. There are no IPOs currently scheduled for the short Labor Day week ahead, though we expect to see the first wave of September launches.

U.S. IPO Weekly Recap: Quiet Week As IPO Market Gears Up For A Busy Fall

Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering

TUCSON, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (“Picard” or the “Company”), a medical technology company that manufactures and sells the only total artificial heart (the “SynCardia Total Artificial Heart”, or “STAH”) approved by the U.S. Food and Drug Administration (“FDA”), and Health Canada, today announced the pricing of its initial public offering (the “Offering”). The Offering consists of 4,250,000 shares of common stock priced at a public offering price of $4.00 per share, for total gross proceeds of $17 million, before deducting underwriting discounts and offering expenses. The shares of common stock have been approved for listing on the NYSE American, LLC and are expected to commence trading on August 29, 2025, under the ticker symbol “PMI.”

Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering

Zacks Investment Research

PCE Comes in Warmer Than Expected

PCE Comes in Warmer Than Expected.

PCE Comes in Warmer Than Expected

Zacks Investment Research

Economy Heating Up on PCE for June

Pre-market and bond yield numbers appear to be in reaction to this morning's economic posts.

Economy Heating Up on PCE for June

Philip Morris shares fall 7% as Q2 revenue misses

Philip Morris International (PMI), the world's largest tobacco company by market capitalization, reported second-quarter results that fell short of analyst revenue expectations, leading to a 7% drop in its share price during Tuesday's trading session.

Philip Morris shares fall 7% as Q2 revenue misses

Picard Medical Seeks IPO On Dropping Revenue And High Valuation

Picard Medical, Inc. has filed to raise $17 million in an IPO. Management's valuation assumptions are extreme, with the IPO seeking a Price/Sales multiple far above industry norms. Picard faces significant risks, including customer concentration and a lack of long-term contracts.

Picard Medical Seeks IPO On Dropping Revenue And High Valuation

See News Rankings

Charts implemented using Lightweight Charts™